The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population.

The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population.

Item
http://www.wikidata.org/entity/Q44726455
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophreniaAntipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychoticsA brief 5-item version of the Neck Disability Index shows good psychometric properties.Cost of antipsychotic polypharmacy in the treatment of schizophrenia.Costs of treating patients with schizophrenia who have illness-related crisis eventsTreatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United StatesAdherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia.Impact of antipsychotic medication on the cost of schizophrenia.Unmet treatment needs in schizophrenia patients: is asenapine a potential therapeutic option?Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands.Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia.Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in JapanImproving psychotherapeutic medication prescribing in Florida: implementation of the Florida Medicaid Drug Therapy Management Program (MDTMP).
P2860

The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population.

Item
http://www.wikidata.org/entity/Q44726455
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The impact of olanzapine, risp ...... care in a medicaid population.
@en
The impact of olanzapine, risp ...... care in a medicaid population.
@nl
type
label
The impact of olanzapine, risp ...... care in a medicaid population.
@en
The impact of olanzapine, risp ...... care in a medicaid population.
@nl
prefLabel
The impact of olanzapine, risp ...... care in a medicaid population.
@en
The impact of olanzapine, risp ...... care in a medicaid population.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
The impact of olanzapine, risp ...... care in a medicaid population.
@en
P2093
P304
P31
P356
10.1111/J.1524-4733.2004.71272.X
P433
P478
P577
P5875
P698
P921